Atlas FDA

Praxis Extended RAS Panel

FDA premarket approval P160038/S019 · decided 2021-07-29

Approval details

PMA number
P160038
Supplement
S019
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Praxis Extended RAS Panel
Generic name
Next generation sequencing oncology panel, somatic or germline variant detection system
Applicant
Illumina, Inc.
Date received
2020-12-30
Decision date
2021-07-29
Days to decision
211 days
Decision code
APPR
Product code
PQP
Advisory committee
Pathology
Expedited review
No
Location
San Diego, CA
Statement
Approval for a manufacturing site located at Illumina Singapore, 29 Woodlands Industrial Park E1, Singapore, South East 757716, for manufacturing of MiSeqDx Cartridge and MiSeqDx Flow Cell.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MISEQDX UNIVERSAL KIT 1.0 (DEN130042)Illumina, Inc.2013-11-19
ILLUMINA MISEQDX CYSTIC FIBROSIS 139-VARIANT ASSAY (K124006)Illumina, Inc.2013-11-19
ILLUMINA MISEQDX PLATFORM (DEN130011)Illumina, Inc.2013-11-19
ILLUMINA MISEQDX CYSTIC FIBROSIS CLINICAL SEQUENCING ASSAY (K132750)Illumina, Inc.2013-11-19
ILLUMINA BEADXPRESS SYSTEM (K093128)Illumina, Inc.2010-04-28
ILLUMINA VERNCODE GENOTYPING TEST FOR FACOR V AND FACTOR II (K093129)Illumina, Inc.2010-04-28